Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Meitheal, through parent company Hong Kong King-Friend, launches generic paclitaxel Protein-bound paclitaxel formulation is used to treat various types of cancer, including metastatic breast cancer ...
Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles. Equivalent to Bristol Myers Squibb's Abraxane, it treats various cancers and is ...
Sandoz is offering a generic paclitaxel formulation, which is the first FDA-approved ANDA to BioScience’s Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable ...
Sandoz has launched a generic paclitaxel formulation. It is the first generic of Abraxis BioScience’s (a Bristol Myers Squibb Co.) Abraxane to be approved by the Food and Drug Administration. Sandoz ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results